ZHOU Huijun

职称:特聘教授

主要研究领域:临床试验,真实世界研究,卫生经济学,卫生技术评估。

电子邮箱:zhou_hj@usst.edu.cn

办公室:管理学院211室

教育背景与工作经历

教育背景

医学学士            南方医科大学(前第一军医大学)                 1998

临床流行病学硕士       新加坡国立大学公共卫生学院                       2005

卫生经济学博士       新加坡国立大学公共卫生学院                        2014


学术经历

2018.09 – 2019.06      上海比利时UCB制药         卫生经济学高级经理 

负责新药上市后真实世界用药安全性的研究,以及产品进入医保目录所需的预算影响分析和成本效益分析

2014.09 – 2018.08      新加坡国家健保集团          卫生经济学专家 

从事真实世界研究、全国糖尿病患者注册数据分析,基于临床试验数据的二次分析和试验后随访的研究设计和数据分析,承担新加坡卫生部委托的医疗技术经济学和临床价值综合评估

2011.01 – 2014.08      新加坡国立大学医学院        卫生经济学分析师 

主要负责研究者发起的临床研究项目的设计和统计分析,包括临床试验、真实世界研究、卫生服务经济学评估等

2008.08 – 2009.08      新加坡国立大学公共卫生学院  流行病学研究员 

流行病学研究的数据分析

2005.09 – 2007.04      新加坡国家眼科中心          生物统计师 

负责新加坡角膜移植注册数据库的统计分析,负责眼科相关临床试验和其他研究的试验设计和统计分析



教研项目及成果

期刊论文

1.WeiJ, Zhu HB, Wang F, Fan Y, Zhou HJ. Clinical utility of flexion-extension ratiomeasured by surface electromyography for patients with nonspecific chroniclow-back pain. J Chin Med Assoc. 2019 Jan;82(1):35-39. doi: 10.1097/JCMA.0000000000000004.(通讯作者)

IF=1.894

2.PanCW, Wu Y, Zhou HJ, Xu BX, Wang P. Health-related quality of life and itsfactors of hemodialysis patients in China. Blood Purif. 2018;45(4):327-333.doi: 10.1159/000485962

IF=2.363

3.C-WPan, D-J Qian, H-J Zhou, S Wang, Y Xu, P Wang. Evaluating health-relatedquality of life impact of chronic conditions among older adults from a ruraltown in Suzhou. Arch Gerontol Geriatr. 2018 May - Jun;76:6-11. doi:10.1016/j.archger.2018.01.008.

IF=2.611

4.TengM, Zhou HJ, Lin L, Lim PH, Yeo D, Goh S, Tjan SY, Lim BP. Cost-effectiveness ofhydrotherapy versus land-based therapy in patients with musculoskeletaldisorders in Singapore. J Public Health (Oxf). 2019 Jun 1;41(2):391-398. doi:10.1093/pubmed/fdy044

IF=1.648

5.C-WPan, XL Cong, H-J Zhou, J Li, H-P Sun, Y Xu, P Wang. Self-reported sleepquality, duration and health-related quality of life in older Chinese: evidencefrom a rural town in Suzhou, china. J Clin Sleep Med. 2017 Jul 14. pii:jc-17-00057.

IF=3.429

6.ChuaHW, Zhou HJ, Khoo CM, Shabbir A, Lomanto D, So JB. Attitudes and concerns ofdiabetic patients towards bariatric surgery as treatment of diabetes. Ann AcadMed Singapore. 2016 Nov;45(11):495-506.

IF=1.041

7.ZhaoYJ, Lin L, Zhou HJ, Tan KT, Chew AP, Foo CG, Oh CT, Lim BP, Lim WS.Cost-effectiveness modelling of novel oral anticoagulants incorporatingreal-world elderly patients with atrial fibrillation. International Journal ofCardiology. 2016; 220:794-801. Oct 1;220:794-801. doi: 10.1016/j.ijcard.2016.06.087. 

IF=6.189

8.WuJT, Zhou J, Naidoo N, Yang WY, Lin XC, Wang P, Ding JQ, Wu CB, Zhou HJ.Determining the cost-effectiveness of endoscopic surveillance for gastriccancer in patients with precancerous lesions. Asia Pac J Clin Oncol. 2016 Jul25. doi: 10.1111/ajco.12569. (通讯作者)

IF=1.959

9.PanCW, Sun HP, Zhou HJ, Ma Q, Xu Y, Luo N, Wang P. Valuing health-related qualityof life in type 2 diabetes patients in china. Med Decis Making. 2016Feb;36(2):234-41. doi: 10.1177/0272989X15606903.

IF=2.335

10.Lin L, Lim WS, Zhou HJ, Khoo AL, Tan KT, Chew AP,Foo CG, Chin JJ, Lim BP. Clinical and safety outcomes of oral antithromboticsfor stroke prevention in atrial fibrillation: a systematic review and networkmeta-analysis. J Am Med Dir Assoc 2015 Dec;16(12):1103.e1-19. doi:10.1016/j.jamda.2015.09.008.  

IF=5.775

11.Lin L, Zhao YJ, Zhou HJ, Khoo AL, Teng M, Soh LB,Lim BP, Sim K. Comparative cost-effectiveness of 11 oral antipsychotics forrelapse prevention in schizophrenia within Singapore using effectivenessestimates from a network meta-analysis. Int Clin Psychopharmacol 2015 Nov 25[epub]

IF=2.968

12.Khoo AL, Zhou HJ, Teng M, Lin L, Zhao YJ, Soh LB,Mok YM, Lim BP, Gwee KP. Network meta-analysis and cost-effectiveness analysisof new generation antidepressants. CNS Drugs. 2015 Aug;29(8):695-712. doi:10.1007/s40263-015-0267-6.

IF=4.394 

13.YH Loo, YC Wong, E Z Cai, CH Ang, A Raju, ALakshmanan, AG Koh, HJ Zhou, TC Lim, SM Moochhala, Charlotte A.E. Hauser.Ultrashort peptide nanofibrous hydrogels for the acceleration of healing ofburn wounds. Biomaterials. 2014 Jun;35(17):4805-14. doi:10.1016/j.biomaterials.2014.02.047.

IF=8.402

14.CL Song, HY Tong, CH Zhao, N Naidoo, H Jia, HJ ZhouProgression of carotid atherosclerosis and associated risk factors in elderlyChinese population (摘要,通讯作者)

Journal of the American College of Cardiology Vol64/16/Suppl C/C230, 2014

IF=17.759

15.Zhou HJ, Dan YY, Naidoo N, Li SC, Yeoh KG. Acost-effectiveness analysis evaluating endoscopic surveillance for gastriccancer for populations with low to intermediate risk. PLoS One. 2013 Dec27;8(12):e83959. doi: 10.1371/journal.pone.0083959. (第一作者)

IF=2.41

16.L Tan, Hui Jun Zhou, M Hartman, I S Ganpathi, KMadhavan, S Chang. Laparoscopic drainage of cryptogenic liver abscess. SurgEndosc. 2013 Mar 15

IF=3.747

17.Zhou HJ, SC Li, N Naidoo, F Zhu, KG Yeoh. Empiricalevidence of the continuing improvement in cost efficiency of an endoscopicsurveillance programme for gastric cancer in Singapore from 2004 to 2010. BMCHealth Serv Res. 2013 Apr 15;13:139. doi: 10.1186/1472-6963-13-139. (第一作者)

IF=1.827

18.Zhou HJ, So JB, Yong WP, Luo N, Zhu F, Naidoo N, LiSC, Yeoh KG. Validation of the functional assessment of cancer therapy-gastricmodule for the Chinese population. Health Qual Life Outcomes. 2012 Nov30;10:145. doi: 10.1186/1477-7525-10-145. (第一作者)

IF=2.143

19.Dirani M, Zhou B, Hornbeak D, Chang BC, Gazzard G,Chia A, Ling Y, Selvaraj P, Young TL, Varma R, Wong TY, Saw SM. Prevalence andcauses of decreased visual acuity in Singaporean Chinese preschoolers. Br JOphthalmol. 2010 Dec;94(12):1561-5

IF=3.806

20.Dirani M, Chan YH, Gazzard G, Hornbeak DM, Leo SW,Selvaraj P, Zhou Brendon Young TL, Mitchell P, Varma R, Wong TY, Saw SM.Prevalence of refractive error in Singaporean Chinese children: the strabismus,amblyopia, and refractive error in young Singaporean Children (STARS) study.Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1348-55.

IF=3.60

21.Low W, Dirani M, Gazzard G, Chan YH, Zhou HJ,Selvaraj P, Au Eong KG, Young TL, Mitchell P, Wong TY, Saw SM. Family history,near work, outdoor activity, and myopia in Singapore Chinese children. BritishJournal of Ophthalmology. 2010 Aug;94(8):1012-6.

IF = 3.806

22.Anshu A, Jun Brendon Zhou, Prathiba J, D.Tan. Irisreconstruction in penetrating keratoplasty—surgical techniques and acase-control study to evaluate effect on graft survival. Am J Ophthalmol 2008;145:203–209

IF=5.052 

23.Tan DT, Janardhanan P, Zhou HJ, Chan YH, Htoon HM,Ang LP, Lim LS. Penetrating keratoplasty in Asian eyes: the Singapore CornealTransplant Study. Ophthalmology. 2008 Jun;115(6):975-982.

IF=8.204

24.S-E Chia, Hui Jun Zhou, MT Tham, E Yap.Possibilities of newer ALAD polymorphism influencing human susceptibility toeffects of inorganic lead on the neurobehavioral functions. NeuroToxicology 28(2007) 312–317

IF=3.379

25.S-E Chia, H-J Zhou, E Yap, M T Tham, N-V Dong, N THong Tu, K-S Chia. Association of renal function and d-aminolevulinic aciddehydratase polymorphism among Vietnamese and Singapore workers exposed toinorganic lead. Occup Environ Med 2006;63:180–186.

IF=3.267

26.Chia SE, Zhou HJ, Tham MT, Yap E, Dong NV, Tu NH,Chia KS. Possible influence of delta-aminolevulinic acid dehydratasepolymorphism and susceptibility to renal toxicity of lead: a study of aVietnamese population. Environ Health Perspect. 2005 Oct;113(10):1313-7.

IF=8.44

 

会议/研讨会论文

1.Possible influence of delta-aminolevulinicacid dehydratase polymorphism and susceptibility to renal toxicity of lead inSingapore and Vietnam

Zhou HJ, Chia SE,Tham MT, Yap E, Dong NV,Tu NH, Chia KS

1st Singapore PublicHealth & Occupational Medicine Conference 2017

2.Clinical Outcomes and Cost-effectiveness ofNovel Oral Anticoagulants Incorporating Real-world Elderly Patients with AtrialFibrillation.

Zhao YJ, Lin L, Zhou HJ,Khoo AL, Tan KT, Chew AP, Foo CG, Oh CT, Lim WS, Lim BP.

International Society forPharmacoeconomics and Outcomes Research (ISPOR), 7th Asia-pacific Conference,2016 Singapore

3.Differences in Cost-Effectiveness Estimatesfor Chronic Hepatitis C Treatment among cohort Markov Model, MarkovMicrosimulation and Discrete Event Simulation

Zhou HJ, Zhao YJ,Wojciech AL C, Lin L, Caro J Jaime, Jorgen Moller, Dan YY, Lim BP

International Society forPharmacoeconomics and Outcomes Research (ISPOR), 7th Asia-pacific Conference,2016 Singapore

4.Does Regression to Normal Glucose Regulationand have Normal Metabolic Control Reduce the Risks of Future DiabetesDevelopment

Wang LY, Zhou HJ, Tan S,Toh M

12th Singapore Public Health &Occupational Medicine Conference 2017

5.Incidence and Risk Factors of PeripheralVascular Disease & Neuropathy among Patients with Type 2 Diabetes Mellituswho had Foot Screening at Primary Care Clinics in Singapore

Zhou HJ, Wang LY, Tan S,Liu D, Toh M

Singapore Health &Biomedical Congress 2017

6.Reversing metabolic syndrome: impact ofregression from pre-diabetes to normal glucose regulation and having optimalmetabolic control on future diabetes risks

Wang LY, Zhou HJ, Tan S,Toh M

Singapore Health &Biomedical Congress 2017

主讲课程

卫生事业管理(本科)

学术活动与社会服务

 

荣誉

2019.01, 上海市东方学者, 上海市教委